dpp 4 inhibitor and glp 1 receptor agonist combination Frontiers GLP-1 receptor agonist versus DPP-4
Description
GLP-1 may nevertheless also directly inhibit glucagon secretion, because -cell-specific GLP-1R KO mice have elevated non-fasting glucagon levels relative to wildtype controls and female -cell-specific GLP-1R KO mice are mildly glucose intolerant with increased secretion of glucagon upon peripheral administration of glucose [607]
The GLP-1 RA are still under prescribed in developed and well-funded health care systems and are not even available in the most modern formulations in some parts of the world
WO 2018109607, 2018
International Journal of Obesity , 33(9), 956961
Microdosing these medications has been linked to reduced levels of pro-inflammatory cytokines like IL-6 and TNF- , which play roles in autoimmune diseases, cardiovascular risk, and aging-related decline
What this study adds: We also confirm cognitive deficits in IIH patients with raised ICP notably in executive function
